Published in Vaccine Weekly, October 20th, 1997
Writing in the journal Nature Medicine, Howard Fine and colleagues at Harvard Medical School's Dana Farber Cancer Institute said rats who had brain tumors induced, and then were injected with an adapted adenovirus, lived longer than rats who did not get the virus.
They were working on the bases of studies that showed giving patients an injection of adenovirus followed by taking the antiviral drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.